hydralazine hydrochloride

Generic: hydralazine hydrochloride

Labeler: preferred pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name hydralazine hydrochloride
Generic Name hydralazine hydrochloride
Labeler preferred pharmaceuticals, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

hydralazine hydrochloride 100 mg/1

Manufacturer
Preferred Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 68788-8087
Product ID 68788-8087_25ed7d1a-86d6-41b4-9a75-0fb5af3aeabb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA040901
Listing Expiration 2026-12-31
Marketing Start 2021-10-05

Pharmacologic Class

Classes
arteriolar vasodilation [pe] arteriolar vasodilator [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687888087
Hyphenated Format 68788-8087

Supplemental Identifiers

RxCUI
905222
UNII
FD171B778Y

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name hydralazine hydrochloride (source: ndc)
Generic Name hydralazine hydrochloride (source: ndc)
Application Number ANDA040901 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 100 TABLET in 1 BOTTLE (68788-8087-1)
source: ndc

Packages (1)

Ingredients (1)

hydralazine hydrochloride (100 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "25ed7d1a-86d6-41b4-9a75-0fb5af3aeabb", "openfda": {"unii": ["FD171B778Y"], "rxcui": ["905222"], "spl_set_id": ["438479d0-ff61-4008-a0fc-1ee44b97cf7f"], "manufacturer_name": ["Preferred Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (68788-8087-1)", "package_ndc": "68788-8087-1", "marketing_start_date": "20211005"}], "brand_name": "Hydralazine Hydrochloride", "product_id": "68788-8087_25ed7d1a-86d6-41b4-9a75-0fb5af3aeabb", "dosage_form": "TABLET", "pharm_class": ["Arteriolar Vasodilation [PE]", "Arteriolar Vasodilator [EPC]"], "product_ndc": "68788-8087", "generic_name": "Hydralazine Hydrochloride", "labeler_name": "Preferred Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Hydralazine Hydrochloride", "active_ingredients": [{"name": "HYDRALAZINE HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA040901", "marketing_category": "ANDA", "marketing_start_date": "20211005", "listing_expiration_date": "20261231"}